Connecticut 2015 Regular Session

Connecticut House Bill HB06292 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 General Assembly Proposed Bill No. 6292
22 January Session, 2015 LCO No. 1457
33 *01457*
44 Referred to Committee on PUBLIC HEALTH
55 Introduced by:
66 REP. CANDELORA, 86th Dist. REP. KOKORUDA, 101st Dist.
77
88 General Assembly
99
1010 Proposed Bill No. 6292
1111
1212 January Session, 2015
1313
1414 LCO No. 1457
1515
1616 *01457*
1717
1818 Referred to Committee on PUBLIC HEALTH
1919
2020 Introduced by:
2121
2222 REP. CANDELORA, 86th Dist.
2323
2424 REP. KOKORUDA, 101st Dist.
2525
2626 AN ACT CONCERNING THE "RIGHT TO TRY" INVESTIGATIONAL TREATMENTS AND DRUGS.
2727
2828 Be it enacted by the Senate and House of Representatives in General Assembly convened:
2929
3030 That the general statutes be amended to allow (1) terminally ill patients to request access to treatment and drugs that have passed the first clinical trial stage of development but have not received final approval by the federal Food and Drug Administration, and (2) physicians, hospitals and manufacturers of investigational drugs, products and devices to make such treatment, drugs, products and devices available to terminally ill patients without being subject to prosecution.
3131
3232 Statement of Purpose:
3333
3434 To allow terminally ill patients the "right to try" experimental treatments and drugs.